- Home
- LE vs QURE Comparison
LE vs QURE Comparison
Compare LE & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- QURE
- Stock Information
- Founded
- LE 1963
- QURE 1998
- Country
- LE United States
- QURE Netherlands
- Employees
- LE N/A
- QURE N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- LE Consumer Discretionary
- QURE Health Care
- Exchange
- LE Nasdaq
- QURE Nasdaq
- Market Cap
- LE 511.4M
- QURE 432.6M
- IPO Year
- LE N/A
- QURE 2007
- Fundamental
- Price
- LE $15.33
- QURE $5.78
- Analyst Decision
- LE Strong Buy
- QURE Buy
- Analyst Count
- LE 2
- QURE 6
- Target Price
- LE $20.00
- QURE $17.00
- AVG Volume (30 Days)
- LE 117.2K
- QURE 797.9K
- Earning Date
- LE 12-05-2024
- QURE 11-05-2024
- Dividend Yield
- LE N/A
- QURE N/A
- EPS Growth
- LE N/A
- QURE N/A
- EPS
- LE N/A
- QURE N/A
- Revenue
- LE $1,442,231,000.00
- QURE $28,587,000.00
- Revenue This Year
- LE N/A
- QURE $157.96
- Revenue Next Year
- LE $2.01
- QURE N/A
- P/E Ratio
- LE N/A
- QURE N/A
- Revenue Growth
- LE N/A
- QURE N/A
- 52 Week Low
- LE $6.35
- QURE $3.73
- 52 Week High
- LE $19.88
- QURE $11.35
- Technical
- Relative Strength Index (RSI)
- LE 43.00
- QURE 43.09
- Support Level
- LE $14.46
- QURE $5.50
- Resistance Level
- LE $17.29
- QURE $7.96
- Average True Range (ATR)
- LE 0.69
- QURE 0.58
- MACD
- LE -0.14
- QURE -0.16
- Stochastic Oscillator
- LE 27.88
- QURE 16.48
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.